经内镜逆行胰胆管造影术(ERCP)是目前诊治胆胰疾病的一项重要技术,术后胰腺炎(PEP)是其最常见的并发症.自ERCP诞生以来,PEP防治便成为国际性研究焦点,近年来研究成果层出不穷,在危险因素、药物预防、预防性胰管支架置入等方面取得诸多进展.但研究结论不甚一致,仍需要临床进一步研究证实.“,”Endoscopic retrograde cholangiopancreatography(ERCP)is an important technique for the diagnosis and treatment of biliary and pancreatic diseases and post-ERCP pancreatitis(PEP)is the most common complication of ERCP. Since the birth of ERCP,the prevention and treatment of PEP has become the focus of international research. In recent years,much progress has been made in the aspects of risk fac-tors,pharmacological prevention,and prophylactic stent implantation in the pancreatic duct. Since these research findings are not consist-ent,further clinical studies are needed to demonstrate such findings.